Mouse Anti-NR3C2 Antibody (1E3) (CBMAB-0758-YC)

Name: Mouse Anti-NR3C2 Antibody (1E3)
SKU: CBMAB-0758-YC
Rating: 5 (1 reviews)

See all NR3C2 antibodies

Compare Online Inquiry

Datasheet

SDS

Request for COA

Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Host Animal

Mouse

Clone

1E3

Application

IP, WB, MA

Immunogen

Recombinant protein domain

Specificity

Human, Common fruit fly

Antibody Isotype

IgG1

Clonality

Monoclonal

Application Notes

The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format

Supernatant

Storage

Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

More Infomation

Target

Full Name

Nr3c2

Introduction

NR3C2 (nuclear receptor subfamily 3, group C, member 2) is the mineralocorticoid receptor, which mediates aldosterone actions on salt and water balance within restricted target cells. NR3C2 functions as a ligand-dependent transcription factor that binds to mineralocorticoid response elements in order to transactivate target genes. Mutations in NR3C2 gene cause autosomal dominant pseudohypoaldosteronism type I and early onset hypertension with severe exacerbation in pregnancy.

Entrez Gene ID

4306

UniProt ID

P08235

Alternative Names

MLR; MR

Function

Receptor for both mineralocorticoids (MC) such as aldosterone and glucocorticoids (GC) such as corticosterone or cortisol. Binds to mineralocorticoid response elements (MRE) and transactivates target genes. The effect of MC is to increase ion and water transport and thus raise extracellular fluid volume and blood pressure and lower potassium levels.

Biological Process

Intracellular steroid hormone receptor signaling pathwayManual Assertion Based On ExperimentIBA:GO_Central
Positive regulation of NIK/NF-kappaB signalingManual Assertion Based On ExperimentIMP:ARUK-UCL
Regulation of transcription by RNA polymerase IIManual Assertion Based On ExperimentIBA:GO_Central
Signal transductionManual Assertion Based On ExperimentTAS:ProtInc

Cellular Location

Cytoplasm
Nucleus
Endoplasmic reticulum membrane
Cytoplasmic and nuclear in the absence of ligand; nuclear after ligand-binding. When bound to HSD11B2, it is found associated with the endoplasmic reticulum membrane.

Involvement in disease

Pseudohypoaldosteronism 1, autosomal dominant (PHA1A):
A salt wasting disease resulting from target organ unresponsiveness to mineralocorticoids. PHA1A is a mild form characterized by target organ defects confined to kidney. Patients may present with neonatal renal salt wasting with hyperkalaemic acidosis despite high aldosterone levels. These patients improve with age and usually become asymptomatic without treatment.
Early-onset hypertension with severe exacerbation in pregnancy (EOHSEP):
Inheritance is autosomal dominant. The disease is characterized by the onset of severe hypertension before the age of 20, and by suppression of aldosterone secretion.

PTM

Phosphorylated.

Amin, M., Syed, S., Wu, R., Postolache, T. T., & Gragnoli, C. (2023). Novel linkage and association of the mineralocorticoid receptor gene (NR3C2) with familial type 2 diabetes and depression and their comorbidity. Aspects of Molecular Medicine, 1, 100003.

Li, J., & Xu, Z. (2022). NR3C2 suppresses the proliferation, migration, invasion and angiogenesis of colon cancer cells by inhibiting the AKT/ERK signaling pathway. Molecular Medicine Reports, 25(4), 1-8.

Li, X., Yang, A., Wen, P., Yuan, Y., Xiao, Z., Shi, H., & Wang, R. (2022). Nuclear receptor subfamily 3 group c member 2 (NR3C2) is downregulated due to hypermethylation and plays a tumor-suppressive role in colon cancer. Molecular and Cellular Biochemistry, 477(11), 2669-2679.

Peng, Y., Xi, X., Li, J., Ni, J., Yang, H., Wen, C., & Wen, M. (2021). miR‐301b and NR3C2 co‐regulate cells malignant properties and have the potential to be independent prognostic factors in breast cancer. Journal of Biochemical and Molecular Toxicology, 35(2), e22650.

Lu, J., Hu, F., & Zhou, Y. (2021). NR3C2-related transcriptome profile and clinical outcome in invasive breast carcinoma. BioMed research international, 2021.

Fan, Y., Li, Y., Zhu, Y., Dai, G., Wu, D., Gao, Z., ... & Xu, D. (2021). miR-301b-3p regulates breast cancer cell proliferation, migration, and invasion by targeting NR3C2. Journal of Oncology, 2021.

Cukier, H. N., Griswold, A. J., Hofmann, N. K., Gomez, L., Whitehead, P. L., Abramson, R. K., ... & Pericak‐Vance, M. A. (2020). Three Brothers With Autism Carry a Stop‐Gain Mutation in the HPA‐Axis Gene NR3C2. Autism research, 13(4), 523-531.

Kumsta, R., Kliegel, D., Linden, M., DeRijk, R., & de Kloet, E. R. (2019). Genetic variation of the mineralocorticoid receptor gene (MR, NR3C2) is associated with a conceptual endophenotype of “CRF-hypoactivity”. Psychoneuroendocrinology, 105, 79-85.

Yang, C., Ma, X., Guan, G., Liu, H., Yang, Y., Niu, Q., ... & Zhuang, L. (2019). MicroRNA‐766 promotes cancer progression by targeting NR3C2 in hepatocellular carcinoma. The FASEB Journal, 33(1), 1456-1467.

Cai, J., Shangguan, S., Li, G., Cai, Y., Chen, Y., Ma, G., ... & Deng, Y. (2019). Knockdown of lncRNA Gm11974 protect against cerebral ischemic reperfusion through miR-766-3p/NR3C2 axis. Artificial cells, nanomedicine, and biotechnology, 47(1), 3847-3853.

Ask a question We look forward to hearing from you.

0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Have you used Mouse Anti-NR3C2 Antibody (1E3)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

$30 eGift Card
Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols

Related Products

Mouse Anti-Nr3c2 Recombinant Antibody (1D5) (CAT#: CBMAB-0435-LY)

Mouse Anti-NR3C2 Recombinant Antibody (CBFYM-3033) (CAT#: CBMAB-M3229-FY)

Mouse Anti-Nr3c2 Recombinant Antibody (4D6) (CAT#: CBMAB-0436-LY)

Mouse Anti-NR3C2 (AA 1-670) Recombinant Antibody (CBFYM-3034) (CAT#: CBMAB-M3230-FY)

Mouse Anti-Nr3c2 Antibody (3F10) (CAT#: CBMAB-0880-YC)

Mouse Anti-Nr3c2 Antibody (2B7) (CAT#: CBMAB-0879-YC)

Mouse Anti-NR3C2 Recombinant Antibody (2B5) (CAT#: CBMAB-N3450-WJ)

Mouse Anti-NR3C2 (AA 2-99) Recombinant Antibody (CBFYM-3035) (CAT#: CBMAB-M3231-FY)

Mouse Anti-NR3C2 Antibody (1A3) (CAT#: CBMAB-0757-YC)

Mouse Anti-NR3C2 Recombinant Antibody (H10E4C9F) (CAT#: CBMAB-N3451-WJ)

Isotype control

For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Request bulk or custom quote Second antibody and isotype control

Contact us

Tel: (USA)
(UK)
Fax:

Global Locations

Email:

Online Inquiry